FHA
IMGN

Flagship Harbor Advisors’s Immunogen Inc IMGN Stock Holding History

Flagship Harbor Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-300
Closed -$1K – 1876
2020
Q3 		$1K Sell
300
-12
-4% -$48 ﹤0.01% 1879
2020
Q2 		$1K Buy
312
+12
+4% +$51 ﹤0.01% 1977
2020
Q1 		$1K Hold
300
– – ﹤0.01% 1826
2019
Q4 		$2K Hold
300
– – ﹤0.01% 1755
2019
Q3 		$0 Hold
300
– – ﹤0.01% 2002
2019
Q2 		$0 Hold
300
– – ﹤0.01% 2008
2019
Q1 		$0 Hold
300
– – ﹤0.01% 1984
2018
Q4 		$1K Hold
300
– – ﹤0.01% 1787
2018
Q3 		$3K Hold
300
– – ﹤0.01% 1854
2018
Q2 		$2K Buy
+300
New +$3.16K ﹤0.01% 1889

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Flagship Harbor Advisors's IMGN Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Immunogen Inc (IMGN) in Q4 2020, closing a stake of 300 shares — an estimated $1K sold.

Flagship Harbor Advisors first reported a position in IMGN in Q2 2018 and held it in 10 quarters. The position peaked at $3K in Q3 2018. 211 funds tracked by Wall St. Rank hold IMGN as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Immunogen Inc position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 300 Immunogen Inc shares in Q4 2020, an estimated $1K.
  • Flagship Harbor Advisors first reported a position in Immunogen Inc in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Immunogen Inc position peaked at $3K in Q3 2018.
  • 211 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.